|
The Worldwide Biochips & Equipments Market Biochips Business Roadmap: Technology Update, Market, Business Trends and DirectionsPublished by: Fuji-Keizai USA, Inc. Published: Jun. 2, 2005 - 176 Pages Table of Contents1. Overview: Business Trends of the Biochip Industry 1.1 Big Picture of the Competitive Landscape for the Biochip Industry 1.2 DNA 1.2.1 DNA Biochips 1.2.2 DNA Biochip Instruments 1.2.3 Custom DNA Biochip Making and Processing Services 1.2.4 DNA Biochip Software and Services 1.3 Lab-on-a-chip Systems 1.3.1 LabChips 1.4 Protein 1.4.1 Protein Biochip 1.5 Special Purpose Biochips 1.5.1 Specialized Biochips and Systems 1.6 Market Size and Forecast 1.7 Applications Roadmap 1.7.1 DNA Biochips 1.7.2 DNA Biochip Making and Analytical Equipment 1.7.3 DNA Biochip Making and Processing Services 1.7.4 Software and Services 1.7.5 Labchip Systems 1.7.6 Protein Biochips and Equipment 1.7.7 Specialized Biochips 1.8 Technology Roadmap (Update Technology and Next Generation Technology) 1.8.1 DNA Biochips 1.8.2 DNA Biochip Equipment 1.8.3 DNA Biochip Making and Processing Services 1.8.4 Biochip Software and Services 1.8.5 Labchips (Lab-on-a-Chip) 1.8.6 Protein Biochips 1.8.7 Specialized Biochips 2. DNA Biochips: Business Roadmap 2.1.1 Market and Business Overview 2.1.2 Competitors and Start up / Venture Map 2.1.3 Market Size and Forecast by Applications 2.1.4 Leading Commercial Vendors' Market Shares 2.1.5 Update Technology - Next Generation Technology Roadmap 2.1.6 Application Development Trends 2.1.7 Product Price Trends 2.1.8 Sales and Distribution 2.1.9 Business Roadmap (Current to Future) 3. DNA Biochip Related Instruments: Business Roadmap 3.1 DNA Biochip Making, Processing and Analysis Instruments 3.1.1 Market Overview 3.1.2 Competitors (Major and Start up / Venture Segment) 3.1.3 Market Size and Forecast by Instrument Segments 3.1.4 Leading Instrument Vendors' Market Share by Segment 3.1.5 Update Technology - Next Generation Technology 3.1.6 Application Development Trends 3.1.7 Product Price Trends 3.1.8 Sales and Distribution 3.1.9 Business Roadmap (Current to Future) 4. DNA Biochip Services: Business Roadmap 4.1 DNA Biochip Making & Processing Services 4.1.1 Market Overview 4.1.2 Competitors 4.1.3 Market Size and Forecast by Segment 4.1.4 Leading Service Provider's Market Share 4.1.5 Update Technology 4.1.6 Application Development Trends 4.1.7 Product Price Trends 4.1.8 Sales and Distribution 4.1.9 Business Roadmap (Current to Future) 5. DNA Biochip Software and Services: Business Roadmap 5.1 Software & Services 5.1.1 Market Overview 5.1.2 Competitors 5.1.3 Market Size and Forecast 5.1.4 Software Vendors' Share 5.1.5 Update Technology and Next Generation Technology 5.1.6 Application Development Trends 5.1.7 Product Price Trends 5.1.8 Sales and Distribution 5.1.9 Business Roadmap (Current to Future) 6. LabChip Systems: Business Roadmap 6.1 LabChip or Lab-on-a-Chip (Microfluidic-Based Biochip Systems) 6.1.1 Market Overview 6.1.2 Competitors (Major and Start up/ Venture Segment) 6.1.3 Market Size and Forecast by Total and Application Segments 6.1.4 Leading Vendors' Market Shares 6.1.5 Update Technology and Technology Roadmap 6.1.6 Application Development Trends 6.1.7 Product Price Trends 6.1.8 Sales and Distribution 6.1.9 Business Roadmap (Current to Future) 7. Protein Biochips: Business Roadmap 7.1 Protein Biochip Systems 7.1.1 Market Overview 7.1.2 Competitors (Major and Start up / Venture Segment) 7.1.3 Market Size and Forecast by Segment 7.1.4 Leading Vendors' Market Shares 7.1.5 Update Technology and Next Generation Technology 7.1.6 Application Development Trends 7.1.7 Product Price Trends 7.1.8 Sales and Distribution 7.1.9 Business Roadmap (Current to Future) 8. Business Trends: Special Purpose Biochip Applications 8.1 Special Purpose Biochips 8.1.1 Market Overview 8.1.2 Massive SNP and Haplotype Genotyping Studies 8.1.3 Competitors Major and Start up / Venture Segment 8.1.4 Market Size and Forecast 8.1.5 Leading Vendors' Market Shares 8.1.6 Update Technology 8.1.7 Application Development Trends 8.1.8 Product Price Trends 8.1.9 Sales and Distribution 8.1.10 Business Roadmap (Current and Future) 9. Activities of Selected Biochip Companies 9.1 Instrument Systems 9.1.1 Applied Biosystems 9.1.2 CapitalBio Corporation 9.1.3 Cepheid 9.1.4 Illumina, Inc. 9.1.5 Luminex Corporation 9.1.6 Molecular Devices Corporation 9.1.7 Perkin Elmer Life and Analytical Sciences, Inc. 9.2 Lab-on-a-chip 9.2.1 Agilent Technologies, Inc., LSCA group 9.2.2 BioTrove, Inc. 9.2.3 Caliper Life Sciences, Inc. 9.2.4 Fluidigm Corporation 9.2.5 Nanogen, Inc. 9.2.6 Nanostream, Inc. 9.3 DNA Biochips 9.3.1 Affymetrix, Inc. 9.3.2 CombiMatrix Corp (Subsidiary of Acacia Research) 9.3.3 GE Healthcare Bio-Sciences (Fmr. Amersham) 9.3.4 MetriGenix, Inc. 9.3.5 Mitsubishi Rayon Co., Ltd.(Genomic Device Group) 9.3.6 NimbleGen Systems, Inc. 9.3.7 PamGene B.V. 9.3.8 Phalanx Biotech Group, Inc. 9.4 Protein Biochips 9.4.1 Biacore International AB 9.4.2 Ciphergen Biosystems, Inc. 9.4.3 Invitrogen Corporation 9.5 Biochip Production and Processing Services 9.5.1 Expression Analysis, Inc. 9.5.2 TeleChem International, Inc./ArrayIt Division 9.6 Software and Services 9.6.1 Gene Logic, Inc. 9.6.2 Spotfire, Inc. 9.6.3 ViaLogy Corporation 10. Opportunities and Conclusions 10.1 Research Findings 10.1.1 FDA Approval BioChip 10.1.2 High-Density Whole Genome Biochips 10.1.3 Less Cost Biochips 10.1.4 High Quality BioChip 10.1.5 Biochip & New Markets 10.1.6 Market Expantion to Asia Pacific 10.1.7 Biochip Standardization 10.1.8 Oligos on DNA Biochips 10.1.9 Multiplex Arraying 10.1.10 Automated Labchip Systems 10.1.11 Protein Biochips 10.1.12 SNPs, Biomarkers 10.2 Conclusions - The Top Growth Markets for Biochip Products 11. Appendix - Company Contact Information by Category Table 1. Market Size and Forecast for the Total US Biochip Market Table 2. Manufacturers of Commercial DNA Biochips Table 3. Market Size Table 4. Market Shares of Commercial DNA Biochip Makers Table 5. Affymetrix Biochip Roadmap Table 6. Agilent Biochip Roadmap Table 7. Arraying and Liquid Handling Robotic Instrument Vendors Table 8. DNA Biochip Scanner Vendors Table 9. DNA Biochip Hybridizer Vendors Table 10. WW Market Size and Forecast for Biochip Instrument Systems by Segments Table 11. Biochip Instrument Market Shares by Segments, 2004 Table 12. Top Arrayer Vendors by Market Rank Table 13. Top Scanner Vendors by Market Rank Table 14. Selected Commercial Biochip Service Firms Table 15. Selected Academic Biochip Core Facilities Table 16. Market Size and Forecast for DNA biochip Services Table 17. Commercial Software and Services Vendors by Product Table 18. Market Size and Forecast for Biochip Software and Services Table 19. Share of Commercial Software Used for Biochip Work by Rank Table 20. Top Biochip Analysis Software Leaders Table 21. Companies Making Labchip/ Lab-on-a-Chip Products Table 22. Total WW Market & Forecast for Lab-on-a-Chip/ Labchip Biochips Table 23. Lab-on-a-Chip/ Labchip Biochip Product Shares by Application Segments Table 24. Top Lab-on-a-Chip/ Labchip/ Microfluidic Systems Vendors by Market Rank Table 25. Companies Making Protein Biochips and Related Products Table 26. Market Size and Forecast for Protein Biochips and Instruments Table 27. Self-made v. Commercial Protein Biochips Table 28. Selected Specialized Biochip Developers Table 29. Market Size and Forecast for Special Purpose BioChips Table 30. Leading Makers' Shares and Rank Table 31. WW Biochip Product Market Shares by Region Table 32. Most Promising Biochip Growth Areas Sorted by CAGR Table 33. Commercial DNA Biochip Manufacturers Table 34. Arraying and Liquid Handling Robotic Equipment Vendors Table 35. DNA Chip Scanner Vendors Table 36. Selected Commercial Biochip and Software Service Firms Table 37. Software and Services Vendors by Biochip Application Table 38. Companies Making Lab-on-a-Chip/ Microfluidics Products Table 39. Selected Specialized Biochip Developers Figure 1. The Biochip Vendor Market Figure 2. Market Size and Forecast for the Total US Biochip Market Figure 3. Comparison of Biochip Segment Market Shares 2004 & 2009 Figure 4. Various Commercial BioChips Figure 5. Market Size and Forecast for DNA Biochips Figure 6. Biochip Market Shares By Application, 2004 Figure 7. WW Market Size and Forecast for Biochip Instrument Systems Figure 8. Market Size and Forecast for DNA biochip Services Figure 9. Market Size and Forecast for Biochip Software and Services Figure 10. Agilent 2100 Bioanalyzer Workflow Figure 11. Agilent ALP 5100 Figure 12. Market Size and Forecast for Lab-on-a-Chip/ Labchip Biochips Figure 13. Lab-on-a-Chip/ Labchip Biochip Product Shares by Application Segments Figure 14. Bio-Rad's Experion Automated Electrophoresis System Figure 15. Diagram of SPR based Protein Biochip for Monitoring Protein Interactions Figure 16. Diagram of the Ciphergen ProteinChip Reader Figure 17. Market Size and Forecast for Protein Biochips Figure 18. Market Size and Forecast for Protein Biochip Instruments Figure 19. Protein Biochip Shares by Application Segments, 2004 Figure 20. Biacore Protein Biochip Instruments Figure 21. Market Size and Forecast for Special Purpose Biochips AbstractThis study provides a broad review of the biochip business roadmap as the market progresses through 2005. What is interesting about biochips is that the field is changing fast. Biochips are becoming more diverse and customers are appearing in other world regions such as China and India. The products from the biochip market are being used to help accelerate the research processes and capabilities of bio-pharmaceutical drug discovery and basic academic bioresearch.During the past ten years, major pharma companies have seen their R&D costs explode as their actual productivity has declined. Drug companies have looked outside of their labs to find drug products faster. As a result, pharma companies have increasingly become motivated research and financial partners with many biotechnology companies. At the same time, pharma companies also want to become customers and partners of biochip companies because these companies have technologies that might help them become more productive faster. New business models are being created. The ideas of pharmacogenomics and targeted therapies have received positive reception from government regulators. Roche and Affymetrix were the first to receive FDA approval for a biochip-based molecular diagnostic test and instrument system. Basic academic research is helping too. Accelerating the drug making process requires modern industrialization of R&D, by using genomics and proteomics technologies such as biochips that the biotechnology companies provide. This report discusses these important topics with interesting findings. This study has found that the total biochip market size in 2004 is about $2.0 billion and is projected to grow to about $5.1 billion in 2009 with a CAGR of 20.2%. The strategies of 29 firms are reviewed. This study uses more than 60 figures and tables to illustrate the findings. Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||